Impairment of vocational activities and financial problems are frequent among German blood cancer survivors.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 Dec 2023
21 Dec 2023
Historique:
received:
28
08
2023
accepted:
18
12
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
epublish
Résumé
Little is known about changes in the personal living conditions of long-term blood cancer survivors in Germany. To gather information about social relationships, work life, overall well-being, and religion, we performed a questionnaire-based retrospective study on 1551 survivors who had been on follow-up for ≥ 3 years (median, 9 years). Most survivors reported that marital status and relationships with relatives and friends remained constant before and after blood cancer. Vocational activities were temporarily impaired for 47.5%, with a median time of 11 months to return to work. More than a third of the patients (35.6%) discontinued work permanently, with disability and retirement pension rates of 7.9% and 38.1%, respectively, at the time of the survey. Financial problems due to reduced income were reported by 26.2%, in particular after relapse or allogeneic transplantation. Patient reports addressing their quality of life showed large variations. It was best in acute leukemia survivors without a history of allogeneic transplantation and worst in patients with myeloproliferative disorders. Religion tended to become more important after blood cancer. In conclusion, vocational impairment and financial problems are frequent among German blood cancer survivors. Efforts should be made at an early stage to reestablish the patients' ability to work.
Identifiants
pubmed: 38129654
doi: 10.1038/s41598-023-50289-9
pii: 10.1038/s41598-023-50289-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22856Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GY1341
Informations de copyright
© 2023. The Author(s).
Références
Smith, A. et al. Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network. Br. J. Cancer 105, 1684–1692 (2011).
pubmed: 22045184
pmcid: 3242607
doi: 10.1038/bjc.2011.450
Parry, C. et al. Cancer survivors: A booming population. Cancer Epidemiol. Biomarkers Prev. 20, 1996–2005 (2011).
pubmed: 21980007
pmcid: 3422885
doi: 10.1158/1055-9965.EPI-11-0729
Fisher, S. G. & Fisher, R. I. The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23, 6524–6534 (2004).
pubmed: 15322522
doi: 10.1038/sj.onc.1207843
Chihara, D. et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br. J. Haematol. 164, 536–545 (2014).
pubmed: 24245986
doi: 10.1111/bjh.12659
Hao, T. et al. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci. Rep. 9, 12070. https://doi.org/10.1038/s41598-019-48445-1 (2019).
doi: 10.1038/s41598-019-48445-1
pubmed: 31427635
pmcid: 6700310
Pulte, D., Jansen, L. & Brenner, H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J. 10, 56. https://doi.org/10.1038/s41408-020-0323-4 (2020).
doi: 10.1038/s41408-020-0323-4
pubmed: 32404891
pmcid: 7221083
Hemminki, K. et al. Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia 37, 854–863 (2023).
pubmed: 36828868
pmcid: 10079539
doi: 10.1038/s41375-023-01852-w
Yanada, M. et al. Potential cure of acute myeloid leukemia: analysis of 1069 consecutive patients in first complete remission. Cancer 110, 2756–2760 (2007).
pubmed: 17948909
doi: 10.1002/cncr.23112
Maurer, M. J. et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J. Clin. Oncol. 32, 1066–1073 (2014).
pubmed: 24550425
pmcid: 3965261
doi: 10.1200/JCO.2013.51.5866
Zuanelli Brambilla, C. et al. Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy. Transplant. Cell. Ther. 27, 771.e1–771.e10 (2021).
Pidala, J., Anasetti, C. & Jim, H. Quality of life after allogeneic hematopoietic cell transplantation. Blood 114, 7–19 (2009).
pubmed: 19336756
pmcid: 2710956
doi: 10.1182/blood-2008-10-182592
Oerlemans, S. et al. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: A systematic review. Ann. Hematol. 90, 993–1004 (2011).
pubmed: 21670973
pmcid: 3150657
doi: 10.1007/s00277-011-1274-4
Bryant, A. L. et al. Patient-reported symptoms and quality of life in adults with acute leukemia: A systematic review. Oncol. Nurs. Forum 42, E91–E101 (2015).
pmcid: 5835968
doi: 10.1188/15.ONF.E91-E101
Raphael, D., Frey, R. & Gott, M. Psychosocial distress in haematological cancer survivors: An integrative review. Eur. J. Cancer Care (Engl) 26, e12640. https://doi.org/10.1111/ecc.12640 (2017).
Joly, F. et al. Late psychosocial sequelae in Hodgkin’s disease survivors: A French population-based case-control study. J. Clin. Oncol. 14, 2444–2453 (1996).
pubmed: 8823322
doi: 10.1200/JCO.1996.14.9.2444
Syse, A. & Kravdal, Ø. Does cancer affect the divorce rate?. Demogr. Res. 16, 469–492 (2007).
doi: 10.4054/DemRes.2007.16.15
Tzelepis, F. et al. Unmet supportive care needs of haematological cancer survivors: Rural versus urban residents. Ann. Hematol. 97, 1283–1292 (2018).
pubmed: 29525897
doi: 10.1007/s00277-018-3285-x
Langer, S. L. et al. Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: A prospective, five-year longitudinal investigation. Psychooncology 19, 190–200 (2010).
pubmed: 19189319
pmcid: 2818001
doi: 10.1002/pon.1542
Cella, D. F. & Tross, S. Psychological adjustment to survival from Hodgkin’s disease. J. Consult. Clin. Psychol 54, 616–622 (1986).
pubmed: 3771879
doi: 10.1037/0022-006X.54.5.616
Horsboel, T. A. et al. Factors associated with work outcome for survivors from haematological malignancies—a systematic literature review. Eur. J. Cancer Care (Engl) 21, 424–435 (2012).
pubmed: 22519911
doi: 10.1111/j.1365-2354.2012.01348.x
Horsboel, T. A. et al. Type of hematological malignancy is crucial for the return to work prognosis: A register-based cohort study. J. Cancer Surviv. 7, 614–623 (2013).
pubmed: 23949119
doi: 10.1007/s11764-013-0300-z
Horsboel, T. A. et al. Risk of disability pension for patients diagnosed with haematological malignancies: A register-based cohort study. Acta Oncol. 53, 724–734 (2014).
pubmed: 24456498
doi: 10.3109/0284186X.2013.875625
Arboe, B. et al. Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation. Clin. Epidemiol. 9, 321–329 (2017).
pubmed: 28652814
pmcid: 5476433
doi: 10.2147/CLEP.S134603
Carlsen, K. et al. Cancer and the risk for taking early retirement pension: A Danish cohort study. Scand. J. Public Health 36, 117–125 (2008).
pubmed: 18519275
doi: 10.1177/1403494807085192
Kiserud, C. E. et al. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncol. 55, 547–553 (2016).
pubmed: 27123741
doi: 10.3109/0284186X.2015.1125015
McGrath, P. D. et al. Returning to work after treatment for haematological cancer: findings from Australia. Support. Care Cancer 20, 1957–1964 (2012).
pubmed: 22033835
doi: 10.1007/s00520-011-1298-2
Parsons, H. M. et al. Impact of cancer on work and education among adolescent and young adult cancer survivors. J. Clin. Oncol. 30, 2393–2400 (2012).
pubmed: 22614977
pmcid: 3675694
doi: 10.1200/JCO.2011.39.6333
Mols, F. et al. Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: A population-based study. Eur. J. Cancer 42, 2794–2801 (2006).
pubmed: 16996260
doi: 10.1016/j.ejca.2006.08.006
Mols, F. et al. Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study. Cancer 109, 1659–1667 (2007).
pubmed: 17330853
doi: 10.1002/cncr.22581
Hensel, M. et al. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann. Oncol. 13, 209–217 (2002).
pubmed: 11885996
doi: 10.1093/annonc/mdf031
Baum, J. et al. Patient-reported patterns of follow-up care in the “Aftercare in Blood Cancer Survivors” (ABC) study. J. Cancer Res. Clin. Oncol. 149, 10531–10542 (2023).
pubmed: 37291404
pmcid: 10423115
doi: 10.1007/s00432-023-04889-7
Fugmann, D. et al. A systematic review: the effect of cancer on the divorce rate. Front. Psychol. 13:828656. https://doi.org/10.3389/fpsyg.2022.828656 (2022).
Mehnert, A. Employment and work-related issues in cancer survivors. Crit. Rev. Oncol. Hematol. 77, 109–130 (2011).
pubmed: 20117019
doi: 10.1016/j.critrevonc.2010.01.004
Seifart, U. & Schmielau, J. Return to work of cancer survivors. Oncol. Res. Treat. 40, 760–763 (2017).
pubmed: 29183032
doi: 10.1159/000485079
Bieri, S. et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant. 42, 819–827 (2008).
pubmed: 18711345
doi: 10.1038/bmt.2008.253
Leunis, A. et al. Impaired health-related quality of life in acute myeloid leukemia survivors: A single-center study. Eur. J. Haematol. 93, 198–206 (2014).
pubmed: 24673368
doi: 10.1111/ejh.12324
Guy, G. P. Jr. et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff. 33, 1024–1031 (2014).
doi: 10.1377/hlthaff.2013.1425
Kornblith, A.B. et al. Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer Leukemia Group B. Ann. Oncol. 9, 297–306 (1998).
Hultcrantz, M. et al. Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: A population-based study. J. Clin. Oncol. 30, 2995–3001 (2012).
pubmed: 22802311
pmcid: 3417050
doi: 10.1200/JCO.2012.42.1925
Anderson, L. A. et al. Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls. Am. J. Hematol. 90, 864–870 (2017).
doi: 10.1002/ajh.24098
Harrison, C. N. et al. The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: Results from the international MPN Landmark survey. Ann. Hematol. 96, 1653–1665 (2017).
pubmed: 28780729
pmcid: 5569657
doi: 10.1007/s00277-017-3082-y
Brochmann, N. et al. Health-related quality of life in patients with Philadelphia-negative myeloproliferative neoplasms: A nationwide population-based survey in Denmark. Cancers 12, 3565. https://doi.org/10.3390/cancers12123565 (2020).
doi: 10.3390/cancers12123565
pubmed: 33260633
pmcid: 7760411
Schoenbeck, K. L. & Flynn, K. E. Health-related quality of life of patients with chronic myeloid leukemia as measured by patient-reported outcomes: Current state and future directions. Curr. Hematol. Malig. Rep. 16, 491–499 (2021).
pubmed: 34648119
doi: 10.1007/s11899-021-00656-y
Pettengell, R. et al. The impact of follicular lymphoma on health-related quality of life. Ann. Oncol. 19, 570–576 (2008).
pubmed: 18056649
doi: 10.1093/annonc/mdm543
Smith, S. K. et al. Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer 115, 3312–3323 (2009).
pubmed: 19452546
doi: 10.1002/cncr.24391
Mesa, R. A. et al. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): An international Internet-based survey of 1179 MPD patients. Cancer 109, 68–76 (2007).
pubmed: 17123268
doi: 10.1002/cncr.22365
Schoenbeck, K. L. et al. Patient-reported functional outcomes in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors. J. Natl. Cancer Inst. 114, 160–164 (2022).
pubmed: 34491344
doi: 10.1093/jnci/djab184
Efficace, F. et al. Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. Leukemia 33, 1598–1607 (2019).
pubmed: 30573776
doi: 10.1038/s41375-018-0325-4
Smith, S. K. et al. Quality of life among long-term survivors of non-Hodgkin lymphoma: A follow-up study. J. Clin. Oncol. 31, 272–279 (2013).
pubmed: 23213093
doi: 10.1200/JCO.2011.40.6249
Tallman, B. et al. Well-being and posttraumatic growth in unrelated donor marrow transplant survivors: A nine-year longitudinal study. Rehabil. Psychol. 55, 204–210 (2010).
pubmed: 20496975
doi: 10.1037/a0019541